Tandem Diabetes Care
TNDM
65 hedge funds and large institutions have $266M invested in Tandem Diabetes Care in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 10 closing their positions.
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
7% more funds holding
Funds holding: 61 → 65 (+4)
11% less capital invested
Capital invested by funds: $299M → $266M (-$32.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
+$14.8M |
| 2 |
Millennium Management
New York
|
+$4.16M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$3.2M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.54M |
| 5 |
Jennison Associates
New York
|
+$2.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$8.06M |
| 2 |
JP Morgan Chase
New York
|
-$7.86M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$2.86M |
| 5 |
CCM
Catapult Capital Management
New York
|
-$1.73M |
TNDM Hedge Fund Activity: Q1 2014 in Review
65 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2014, worth a combined $266M — down 11% from $299M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TNDM positions and 10 closed out — a net gain of 5 holders — while 25 added to existing stakes and 18 trimmed.
The largest buyer was TAMRO Capital Partners, opening a new position worth an estimated $14.8M. The largest seller was Goldman Sachs, exiting entirely with an estimated $8.06M sold.
- 65 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2014, up from 61 in Q4 2013.
- Funds reported $266M of Tandem Diabetes Care stock for Q1 2014, down 11% quarter-over-quarter.
- 15 funds opened new Tandem Diabetes Care positions in Q1 2014 and 10 closed out, a net change of +5 holders.
- The largest Tandem Diabetes Care buyer in Q1 2014 was TAMRO Capital Partners, an estimated $14.8M added.
- The largest Tandem Diabetes Care seller in Q1 2014 was Goldman Sachs, an estimated $8.06M sold.
Based on aggregated 13F filings for Q1 2014.